Financials
- Market Capitalization 18.58 M
- Employee 5
- Founded 1979
- CEO N/A
- Website www.dyadic.com
- Headquarter Delaware, United States
- FIGI BBG000L276R1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.27
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4546 | NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.77 USD | +0.53% | -2.84% | -3.08% | -71.00% | 20.38 M USD | ||
| 4548 | CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.90 USD | +6.23% | +2.84% | +73.65% | +96.61% | 20.86 M USD | ||
| 4554 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 12.21 USD | -3.17% | -25.14% | -3.48% | +108.72% | 19.77 M USD | ||
| 4559 | LPCN Lipocine Inc. - Common Stock | 2.34 USD | -0.85% | +1.74% | +9.86% | -19.31% | 19.29 M USD |